Trials / Completed
CompletedNCT03978793
MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence Among HIV+ Prescription Opioid Users
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 31 (actual)
- Sponsor
- Ohio State University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study compares several different antiretroviral adherence measures, including digital pills, in HIV+ individuals who are maintained on opioid analgesics.
Detailed description
This study compares digital pills, electronic pill bottles, self-report, and dried blood spots, in measuring adherence to antiretroviral medications containing emtricitabine and tenofovir.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MyTPill, a digital pill | MyTPill is a digital pill containing an approved medication |
Timeline
- Start date
- 2021-02-01
- Primary completion
- 2025-03-12
- Completion
- 2025-04-30
- First posted
- 2019-06-07
- Last updated
- 2025-08-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03978793. Inclusion in this directory is not an endorsement.